Factors predicting the long-term success of maintenance cyclosporine monotherapy after kidney transplantation

Transplantation

Volumn 69, Issue 7, 2000, Pages 1327-1332

  Hurault De Ligny, Bruno ^a   Toupance, Olivier ^b   Lavaud, Sylvie ^b   Bauwens, Marc ^c   Peyronnet, Pierre ^d   Le Meur, Yann ^d   Ryckelynck, Jean Philippe ^a   Jolly, Damien ^b   Leroux Robert, Claude ^d   Touchard, Guy ^c  

^a CHU Clemenceau   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLOMERULOPATHY; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL RATE;

EID: 0342264473     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00019     Document Type: Article

References (16)

1. Thiel G, Back A, Spondin M, et al. Long-term benefits and risks of cyclosporin A (Sandimmun): an analysis at 10 years. Transplant Proc 1994; 26: 2493.
2. Opelz G. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994; 58: 443.
3. Maiorca R, Cristinelli L, Brunori G et al. Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine. Transplant Proc 1988; 20, suppl 3: 121.
4. Touchard G, Hauet T, Cogny Van Weydevelt F, et al. Maintenance cyclosporin monotherapy after renal transplantation-clinical predictors of long-term outcome. Nephrol Dial Transplant 1997; 12: 1956.
5. Lloveras J, Puig JM, Comerma I, et al. Requirements for safe prednisolone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine. Transplant Proc 1990; 22: 1693.
6. Schleibner S, Schneeberger H, Hillebrand G, et al. Cyclosporine monotherapy: an ideal long-term immunosuppression? Transplant Proc 1990; 22: 1695.
7. Tamm M, Thiel G, Huser B, et al. Cyclosporine monotherapy after kidney transplantation since 1983. Transplant Proc 1991; 23: 997.
8. Morales JM, Munoz Cepada MA, Sancho S, et al. Cyclosporine (cya) alone as therapy of maintenance in renal transplants (rt) patients over fifty years old, a prospective study [Abstract]. J Am Soc Nephrol 1991; 2: 509.
9. Hillebrand G, Schneeberger H, et al. Ten years experience with cyclosporine monotherapy after renal transplantation. Transplant Proc 1993; 25: 513.
10. Burke J, Pirsch J, Ramon E, et al. Long term efficacy and safety of cyclosporin in renal transplant recipients. N Engl J Med 1994; 331: 358.
11. Schulak JA, Mayes JT, Moritz CE, et al. A prospective randomized trial of prednisolone versus no prednisolone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients. Transplantation 1990; 49: 327.
12. Hricik DE, Almawi WY, Strom TB. Trends in the use of glucocorticoïds in renal transplantation. Transplantation 1994; 57: 979.
13. Ratcliffe PJ, Dudley CR, Higgins RM, et al. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 348: 643.
14. Hollander AAMJ, Hene R, Hermans J, et al. Late prednisone withdrawal in cyclosporin-treated kidney transplant patients: a randomized study. J Am Soc Nephrol 1997; 8: 294.
15. Romani F, Belli LS, De Carlis L, et al. Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial. Transplant Proc 1994; 26: 2683.
16. Livi U, Bortolotti U, Faggian G, et al. Safety of cyclosporin monotherapy after heart transplantation. Transplant Proc 1990; 22: 1441.